Stocks
Vyome Holdings, Inc.HIND
NASDAQHealthcareBiotechnology$1.80
Price as of · delayed, not real-time
A healthcare company focused on developing and commercializing innovative therapies, Vyome Holdings, Inc. operates in the pharmaceutical and biotechnology space. Its pipeline targets dermatological and infectious disease indications, and investors track it for its clinical-stage assets and potential partnerships.
52W Range: $1.75-$6.56
Congressional Interest in Vyome Holdings, Inc. (HIND)
No congressional trades have been disclosed for Vyome Holdings, Inc. (HIND) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading HIND?
No congressional trades found for this stock.